Effect of +294T/C Variant Polymorphism of Human Peroxisome Proliferator-Activated Receptor Δ Gene on Metabolic Syndrome

阿孜古丽·买合买提
DOI: https://doi.org/10.3969/j.issn.1000-2065.2008.10.006
2008-01-01
Abstract:Objective To investigate the impact of single nucleotide polymorphism(SNP) of peroxisome proliferator-activated receptor δ gene(PPARδ) +294T/C on metabolic syndrome(MS).Methods The genotypes of PPARδ+294T/C were determined by touch-down PCR in 346 Chinese of Han nationality in Nanjing,including 228 subjects without metabolic syndrome and 118 patients with metabolic syndrome.All the subjects underwent oral glucose tolerance test(OGTT) and synchronic insulin releasing test(IRT) to determine the β-cell secretion function and insulin sensitivity.Plasma lipids,blood pressure,body mass index(BMI) and waist to hip ratio(WHR) were also measured for each subject.Results In MS group,the subjects with PPARδ +294CC had a higher level of triglyceride(TG) than those with PPARδ +294TT(P0.05),and subjects in MS group with C allele in PPARδ +294(TC+CC) a lower homeostasis model assessment of β-cell secretion function(HOMA-β) than those with PPARδ +294TT(P0.05),while subjects in Non-MS Group had a higher LDL-C/HDL-C ratio than those with PPARδ +294TT(P0.05).Conclusions There is a correlation between PPARδ gene +294T/C variant polymorphism and a lower β-cell secretion function in MS group,while +294CC genotype carriers also exhibited a high TG level.PPARδ+294T/C plays a role in the dyslipidemia in Non-MS group.
What problem does this paper attempt to address?